AbbVie is an international pharmaceutical company with a multitude of pharmaceutical products available. In 2023, once again, the company’s top revenue generating drug was Humira. In that year, Humira generated about 14.4 billion U.S. dollars in revenue for AbbVie. That amount was significantly lower than in previous years, due to generic versions entering the market. Humira is used to treat several types of autoimmune diseases including certain types of arthritis and Crohn’s disease.
AbbVie’s company profile
Abbvie was founded in 2013, originally a spin-off of Abbott Laboratories, and is based out of Chicago, Illinois, in the United States. In recent years the company has experienced some growth which can also be seen in their increasing number of employees. The company has also experienced exceptional growth in their annual revenues. Finally, AbbVie has experienced significant growth in its total assets in recent years. However, 2023 showed some stagnating tendencies for the company.
AbbVie’s global positioning
Despite being a young company, AbbVie is among the top pharmaceutical companies. AbbVie is placed among other top companies such as Pfizer and Johnson & Johnson in terms of their prescription sales and expenditure on research and development. The company is also among the top pharmaceutical companies in terms of its net profits per employee.
AbbVie's key product revenues in 2022 and 2023
(in million U.S. dollars)
Adjust the presentation of the statistic and data points.
Share the statistic on social media channels or embed the statistic in your
website using "Embed Code", where available.
Cite this statistic and select one of the following formats: APA, Chicago, Harvard, MLA & Bluebook.
The statistic is available in another language. Switch language.
Print the statistic including description and metadata.
Chart type
AbbVie's key product revenues in 2022 and 2023
Share this statistic
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Learn more about how Statista can support your business.
AbbVie. (February 20, 2024). AbbVie's key product revenues in 2022 and 2023 (in million U.S. dollars) [Graph]. In Statista. Retrieved February 19, 2025, from https://www.statista.com/statistics/417063/revenue-of-abbvie-from-key-products/
AbbVie. "AbbVie's key product revenues in 2022 and 2023 (in million U.S. dollars)." Chart. February 20, 2024. Statista. Accessed February 19, 2025. https://www.statista.com/statistics/417063/revenue-of-abbvie-from-key-products/
AbbVie. (2024). AbbVie's key product revenues in 2022 and 2023 (in million U.S. dollars). Statista. Statista Inc.. Accessed: February 19, 2025. https://www.statista.com/statistics/417063/revenue-of-abbvie-from-key-products/
AbbVie. "Abbvie's Key Product Revenues in 2022 and 2023 (in Million U.S. Dollars)." Statista, Statista Inc., 20 Feb 2024, https://www.statista.com/statistics/417063/revenue-of-abbvie-from-key-products/
AbbVie, AbbVie's key product revenues in 2022 and 2023 (in million U.S. dollars) Statista, https://www.statista.com/statistics/417063/revenue-of-abbvie-from-key-products/ (last visited February 19, 2025)
AbbVie's key product revenues in 2022 and 2023 (in million U.S. dollars) [Graph], AbbVie, February 20, 2024. [Online]. Available: https://www.statista.com/statistics/417063/revenue-of-abbvie-from-key-products/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.